JP2011505829A5 - - Google Patents

Download PDF

Info

Publication number
JP2011505829A5
JP2011505829A5 JP2010537899A JP2010537899A JP2011505829A5 JP 2011505829 A5 JP2011505829 A5 JP 2011505829A5 JP 2010537899 A JP2010537899 A JP 2010537899A JP 2010537899 A JP2010537899 A JP 2010537899A JP 2011505829 A5 JP2011505829 A5 JP 2011505829A5
Authority
JP
Japan
Prior art keywords
primer pair
gene
genes
marker gene
steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010537899A
Other languages
English (en)
Japanese (ja)
Other versions
JP5514733B2 (ja
JP2011505829A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2008/051446 external-priority patent/WO2009078793A1/en
Publication of JP2011505829A publication Critical patent/JP2011505829A/ja
Publication of JP2011505829A5 publication Critical patent/JP2011505829A5/ja
Application granted granted Critical
Publication of JP5514733B2 publication Critical patent/JP5514733B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010537899A 2007-12-14 2008-12-12 療法に対する応答を予測するための方法 Active JP5514733B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0702789-9 2007-12-14
SE0702789 2007-12-14
PCT/SE2008/051446 WO2009078793A1 (en) 2007-12-14 2008-12-12 Method for predicting the response to a therapy

Publications (3)

Publication Number Publication Date
JP2011505829A JP2011505829A (ja) 2011-03-03
JP2011505829A5 true JP2011505829A5 (cg-RX-API-DMAC10.html) 2012-02-02
JP5514733B2 JP5514733B2 (ja) 2014-06-04

Family

ID=40795763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010537899A Active JP5514733B2 (ja) 2007-12-14 2008-12-12 療法に対する応答を予測するための方法

Country Status (6)

Country Link
US (2) US8574834B2 (cg-RX-API-DMAC10.html)
EP (1) EP2220489B1 (cg-RX-API-DMAC10.html)
JP (1) JP5514733B2 (cg-RX-API-DMAC10.html)
AU (1) AU2008339090A1 (cg-RX-API-DMAC10.html)
CA (1) CA2708267C (cg-RX-API-DMAC10.html)
WO (1) WO2009078793A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012122228A2 (en) * 2011-03-07 2012-09-13 Temple University - Of The Commonwealth System Of Higher Education Biomarkers of chronic obstructive pulmonary disease
WO2016127035A1 (en) * 2015-02-05 2016-08-11 Duke University Methods of detecting osteoarthritis and predicting progression thereof
US20180193270A1 (en) 2016-11-29 2018-07-12 PureTech Health LLC Exosomes for delivery of therapeutic agents
US20200360364A1 (en) * 2018-01-31 2020-11-19 Flagship Pioneering Innovations V, Inc. Methods and compositions for treating inflammatory or autoimmune diseases or conditions using chrna6 activators
US11946928B2 (en) 2021-05-20 2024-04-02 Trustees Of Boston University Methods and compositions relating to airway dysfunction
JP7710407B2 (ja) * 2022-03-31 2025-07-18 日立建機株式会社 作業機械

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002300883A (ja) * 2001-04-05 2002-10-15 Jenokkusu Soyaku Kenkyusho:Kk ステロイド応答性の検査方法
US7384736B2 (en) 2001-09-06 2008-06-10 Decode Genetics Ehf. Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
WO2003062792A2 (en) 2002-01-22 2003-07-31 Trustees Of The University Of Pennsylvania Methods for determining drug responsiveness
WO2005116268A2 (en) * 2004-05-27 2005-12-08 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Differential expression of molecules associated with acute stroke
SI2380584T1 (sl) * 2005-07-01 2014-04-30 Index Pharmaceuticals Ab Imunostimulatorni postopek
AU2006306805A1 (en) 2005-10-28 2007-05-03 Index Pharmaceuticals Ab Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
AU2007309726A1 (en) * 2006-04-07 2008-05-02 Xdx, Inc. Steroid responsive nucleic acid expression and prediction of disease activity

Similar Documents

Publication Publication Date Title
US10132809B2 (en) Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis
CN110205378B (zh) 一组脊柱结核血浆miRNA联合诊断标记物及其应用
AU2011237669A1 (en) Circulating biomarkers for disease
CN107502667B (zh) 与ldl-c水平相关的基因功能性遗传变异及相关应用
JP2023532444A (ja) 呼吸器病原体を診断し、covid-19に関連する転帰を予測する方法
CN114875140A (zh) 包括外泌体miR-106b-3p、miR-1294等在肺癌诊断中的应用
Lima et al. Genetic variants in RORA are associated with asthma and allergy markers in an admixed population
Park et al. Mycobiota and the contribution of yeasts in floor dust of 50 elementary schools characterized with sequencing internal transcribed spacer region of ribosomal DNA
Liu et al. Advances in asthma 2015: Across the lifespan
Apter Advances in adult asthma diagnosis and treatment in 2012: potential therapeutics and gene-environment interactions
Shaker et al. Impact of single nucleotide polymorphism in tumor necrosis factor-α gene 308G/A in Egyptian asthmatic children and wheezing infants
CN114164276B (zh) 用于肺癌诊断的试剂盒、装置及方法
CN112048555A (zh) 胶质瘤患者生存预测的预后分类系统
WO2014066894A1 (en) Biomarkers for nod2 and/or rip2 activity related application
CN119265302A (zh) 用于诊断肝癌的生物标志物组合、Logistics模型及其应用
Pousada et al. K198N polymorphism in the EDN1 gene in patients with pulmonary arterial hypertension
TW201140051A (en) Gene group test structure
Jiang et al. Serum miR-21 and miR-26a levels negatively correlate with severity of cirrhosis in patients with chronic hepatitis B
CN110257504A (zh) 一种难治性哮喘检测标记物的筛选方法及其应用
RU2547575C1 (ru) Способ прогнозирования течения хронической сердечной недостаточности
Tandarto et al. miR-155 EXPRESSION UTILIZATION AS A POTENTIAL DIAGNOSTIC BIOMARKER OF HEART FAILURE: A SYSTEMATIC REVIEW: Received 2023-01-03; Accepted 2023-02-09; Published 2023-03-09
VAN LE et al. Sarcoidosis models: past, present, and future
CN104164427B (zh) 一种与吸烟成瘾相关的snp标志物及其应用
JP2022545357A (ja) 上皮成長因子受容体阻害剤によって引き起こされる皮膚副作用のリスクを評価するための方法、その検出キット、およびその使用
Nyangiri et al. Variants of IL6, IL10, FCN2, RNASE3, IL12B and IL17B loci are associated with Schistosoma mansoni worm burden in the Albert Nile region of Uganda